tirzepatide pediatrics as a Potential Disease-Modifying Therapy in Lipedema: A Narrative Review on Bridging Metabolism, Inflammation, and Fibrosis tirzepatide pediatric Is Mounjaro (tirzepatide)

[22] B 12 deficiency in pregnant women is increasingly common [23] and has been shown to be associated with major maternal health implications, including increased obesity, [23] higher body mass index (BMI), [24] insulin resistance, [22] gestational diabetes, and type 2 diabetes (T2D) in later life

Christen S, Redeuil K, Goulet L, Giner MP, Breton I, Rota R, et al

While lipedema is not primarily a lymphatic disorder, it can eventually impact lymphatic function as the condition progresses

When looking at people who fully adhered to the medication schedule (a weekly injection under the skin), those on the 7.2 milligram dose lost an average 20.7% body weight after 72 weeks, compared to 17.5% lost body weight for the 2.4 milligram group, and 2.4% lost body weight for the placebo group